Coloplast A/s Class B · OMXCOP:COLO_B

Coloplast A/s Class B — Q3 2016/17 Earnings Presentation

7 slides from Coloplast A/s Class B's earnings presentation, Aug 16, 2017

  1. Slide 1: Coloplast Earnings Conference Call Q3 2016/17

    Coloplast Earnings Conference Call Q3 2016/17 16 August 2017

  2. Slide 2: Forward-looking statements

    Forward-looking statements The forward-looking statements contained in this presentation, including forecasts of sales and earnings performance, are not guarantees of future results and are subject to risks, uncertainties and assumptions that are difficult to predict. The forward-looking statements

  3. Slide 3: Coloplast delivered Q3 organic growth of 8% and an EBIT margin of 33%

    Coloplast delivered Q3 organic growth of 8% and an EBIT margin of 33% before one-off adjustment for Veterans Affairs Q3 Highlights Revenue growth +7% • Q3 organic growth of 8% (6% reported growth) Reported revenue (DKKm) +6% • Reported revenue in Q3 negatively Organic growth 11,548 +8% 10,942 affect

  4. Slide 4: 9M organic growth of 7% with good performance across most business areas and geographies

    9M organic growth of 7% with good performance across most business areas and geographies 9M 16/17 revenue by business area 9M 16/17 revenue by geography Business Reported revenue Organic growth Share of organic Geographic Reported revenue Organic growth Share of organic area DKKm growth area DKKm gr

  5. Slide 5: 9M EBIT in constant currencies & before one-off adjustment for VA grew 9%

    9M EBIT in constant currencies & before one-off adjustment for VA grew 9% corresponding to an EBIT margin of 33% Comments EBIT margin development • EBIT grew 4% to DKK 3,705m with a reported margin of 32% (33% in constant currencies, before one-off revenue adjustment) compared to 33% last year • Gro

  6. Slide 6: Updated financial guidance for 2016/17

    Updated financial guidance for 2016/17 Guidance 16/17 Guidance 16/17 (DKK) Long term ambition Sales growth 7-8% (organic) ~6% from 7-8% 7-9% p.a. 33-34% (constant EBIT margin ~32% from ~33% +50-100 bps p.a. exchange rates) CAPEX (DKKm) ~700 4-5% of sales Tax rate ~23 Page 6

  7. Slide 7: Our mission, values and vision

    Our mission Making life easier for peoplé with intimate healthcare needs Our values Closeness... to better understand. - Passion... to make a difference Respect and responsibility... to 0 guide | US: Our vision Setting the global standard for listening and responding: Coloplast A/S - Ostomy Care / C

Coloplast — Q3 2016/17 Earnings Presentation on 6ix